See also this year's filing and all EDGAR filings for this company.
PDF Report 0001607678_2020_Viking_Therapeutics_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001607678')"} |
Graph
Absolute values for 0001607678, Viking Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 283,501,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 755,000 |
| 4 | LiabilitiesCurrent | 6,777,000 |
| 5 | LiabilitiesNoncurrent | 360,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 9,128,000 |
| 9 | ResearchAndDevelopmentExpense | 23,559,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 6,908,000 |
| 13 | remainder_ComprehensiveNetIncome | 435,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 284,256,000 |
| 1 | Liabilities | 7,137,000 |
| 2 | Expenses | 32,687,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 277,119,000 |
| 5 | NetIncome | -25,779,000 |
| 6 | ComprehensiveNetIncome | -25,561,500 |
| 7 | BaseVar | 165,711,500 |
| 8 | EconomicCapitalRatio | 3.10 |
Edgar->Model Mapping
Feature Distribution
Change over Time
